Fidelity Investments’s ProShares UltraShort Health Care RXD Stock Holding History

Fidelity Investments’s Portfolio RXD Stock Details RXD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1	Closed	-$12	–	5661
2023 Q4	$12	Buy	+1	New	+$26	﹤0.01%	5298

Other funds holding RXD

IMC Chicago Chicago, Illinois $419B AUM 72.04% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments's RXD Position: Q1 2024 in Review

Fidelity Investments sold out of ProShares UltraShort Health Care (RXD) in Q1 2024, closing a stake of 1 share — an estimated $12 sold.

Fidelity Investments first reported a position in RXD in Q4 2023 and held it in 1 quarter. The position peaked at $12 in Q4 2023. 3 funds tracked by Wall St. Rank hold RXD as of Q1 2024.

Fidelity Investments reported no remaining ProShares UltraShort Health Care position as of Q1 2024 after selling out during the quarter.
Fidelity Investments sold 1 ProShares UltraShort Health Care share in Q1 2024, an estimated $12.
Fidelity Investments first reported a position in ProShares UltraShort Health Care in Q4 2023 and held it in 1 quarter.
Fidelity Investments's ProShares UltraShort Health Care position peaked at $12 in Q4 2023.
3 funds tracked by Wall St. Rank held ProShares UltraShort Health Care as of Q1 2024.

Based on Fidelity Investments's 13F filing for Q1 2024, filed 13 May 2024.